EANO 2026 – Neuro-Oncology, Rome
Join our partner Medwave at EANO 2026 in Rome!
From 24–27 September 2026, the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026) will be held in Rome, Italy.
EANO is Europe’s leading multidisciplinary organisation for neuro-oncology. It represents all medical and scientific disciplines involved in the prevention, diagnosis, and treatment of tumours of the central and peripheral nervous system. The meeting showcases the latest advances in neuro-oncology research, imaging and clinical trials.
This year, ClinFlows will be represented by our partner Medwave – a Dutch imaging CRO with extensive expertise in neuro-oncology and clinical research. Medwave combines advanced MRI imaging and central review methods. For high-quality endpoint analysis, Medwave uses the latest neuroimaging software, including Mint Lesion and Olea Medical.
Together, ClinFlows and MedWave provide one integrated solution for secure imaging data exchange and central reading, helping sponsors, CROs and research sites to set up reliable, regulatory-compliant imaging workflows.
Planning a clinical trial for glioblastoma or brain metastases?
Schedule a meeting with MedWave’s Team in Rome
John Uiters, Founder and CEO of MedWave, with 25+ years of clinical trial experience in Neuro-Oncology
Our Expertise and Proven Impact
Since 2011, the partnership between ClinFlows and Medwave has supported multiple investigator-initiated and multicentre glioblastoma studies.
Representative projects include:
- INTRAGO II – Phase III trial in newly diagnosed glioblastoma
- GLORIA – Phase I/II trial in newly diagnosed glioblastoma
- ATLAS / NOA-29 – Phase III trial in newly diagnosed temporal lobe glioblastoma
https://link.springer.com/article/10.1186/s12885-025-13682-3
